Efor acquires No deviation
Efor agreed to acquire No deviation. Reported deal value: Undisclosed. Status: Announced. Sector: Life Sciences. Target headquarters context: Singapore, Central Singapore, Singapore.
This page summarizes publicly available information about the transaction as of 2026-03-03. Figures and status may change as filings and press coverage update.
March 3, 20 26 /PRNewswire/ — Efor , a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore -based No deviation , a company recognized for its expertise in Commissioning, Qualification & Validation , Computer System Validation , Quality Compliance and Digital Enablement
Deal timeline
This transaction is classified in Life Sciences. Figures and status may change as sources update.